This is a rare genetic condition that affects the pancreas, bone marrow, and skeleton. It causes the pancreas to not produce enough digestive enzymes, leading to poor digestion and weight loss. It can also cause problems with blood cell production and bone growth.
Every report comes from a Lived member, sent anonymously.
Have you tried Pancrelipase for Shwachman-Diamond Syndrome?
Shwachman-Diamond syndrome (SDS) is a rare inherited condition that mainly affects three parts of the body: the bone marrow, the pancreas and the bones. It usually shows itself in the first months of life, although milder cases are sometimes recognized only later in childhood or even in adulthood. In the bone marrow, SDS reduces the production of neutrophils, the white blood cells that are the body's first defense against bacteria. Low neutrophil counts (neutropenia) may be constant or come and go, and they leave people more prone to infections such as pneumonia, ear infections and skin infections. Less often, red blood cells or platelets are also low, which can cause tiredness, paleness or easy bruising. In the pancreas, the cells that make digestive enzymes do not develop properly. Without enough enzymes, food, especially fat, is poorly absorbed, so babies often have loose, greasy, foul-smelling stools and gain weight slowly. Many people with SDS also have changes in how their bones grow, most often at the hips and knees, and most are shorter than average. SDS matters beyond these early problems because it carries a lifelong, higher-than-average risk of serious bone marrow disorders, including myelodysplastic syndrome (MDS, in which the marrow makes abnormal, poorly working blood cells) and acute myeloid leukemia (AML), a fast-growing blood cancer. That risk shapes much of the long-term care.
SDS is caused by changes in genes, not by anything a parent or child did. In about 90 percent of people, the change is in a gene called SBDS, which helps cells build ribosomes, the structures that make proteins. When this process works less well, organs that depend on making many new cells, such as the bone marrow and the pancreas, are particularly affected. Most SDS is inherited in an autosomal recessive pattern: a person develops it only when both copies of the gene are altered. Their parents usually each carry one altered copy and have no symptoms, so SDS often appears in a family with no known history of it. A few other genes cause the same or a similar condition. One of them, SRP54, can cause disease with a single altered copy, usually as a new change in the child. Because the pattern differs by gene, genetic counseling helps families understand what a diagnosis means for brothers and sisters and for future pregnancies. SDS is estimated to affect roughly 1 in 80,000 newborns, and because symptoms can be mild, it is probably underdiagnosed.
SDS is usually suspected in an infant or young child who has the combination of poor growth, digestive problems and low neutrophil counts, often along with repeated infections. Symptoms typically begin within the first few months, but diagnosis often comes a year or more later because each problem on its own has more common explanations. The assessment looks at each affected system. Repeated complete blood counts check neutrophils, red cells and platelets. A stool test for fecal elastase, an enzyme made by the pancreas, is the main test of pancreatic function; low results suggest the pancreas is not producing enough enzymes. Blood tests for pancreatic enzymes and imaging that shows fat replacing pancreatic tissue can add support. A sweat test is often done because cystic fibrosis also causes pancreatic problems with infections; in SDS the sweat test is normal. X-rays can show the characteristic bone changes, and a bone marrow sample (aspiration and biopsy) shows how the marrow is working and whether there are chromosome changes. Genetic testing confirms the diagnosis when it finds disease-causing changes, most often in both copies of SBDS. When no genetic cause is found, experienced specialists can still make a clinical diagnosis based mainly on the combination of pancreatic and bone marrow problems. Siblings are usually evaluated too, since mildly affected brothers or sisters may need monitoring.
There is no medicine that corrects the underlying genetic problem, so treatment manages each part of the condition. Care is usually coordinated by a team that includes a hematologist (blood specialist), a gastroenterologist and dietitian, and, as needed, endocrine, orthopedic, dental and developmental specialists. The hematologist plays a central role because the marrow carries the most serious risks. For the digestive problems, pancreatic enzyme replacement therapy means enzyme capsules taken with meals and snacks so fat and other nutrients can be absorbed. Supplements of vitamins A, D, E and K are common because these fat-soluble vitamins are hard to absorb, and some children need a higher-calorie diet to support growth. Infections are treated promptly with antibiotics, sometimes given intravenously in the hospital. For people whose neutrophil counts are very low and who have frequent infections, G-CSF (granulocyte colony-stimulating factor), an injected medicine that prompts the marrow to make more neutrophils, can help. It is also used before surgery or dental procedures. Long-term use is weighed carefully, because it may increase the risk of leukemia, although that link has not been proven. When red cells or platelets fall very low, transfusions may be needed, and doctors and dentists take extra steps to limit bleeding before procedures. A hematopoietic stem cell transplant (bone marrow transplant) is the only treatment that can cure the blood-related part of SDS. It does not change the pancreas or bones, and it carries serious risks, so it is usually reserved for severe marrow failure, MDS or AML; overall, about 10 to 20 percent of people with SDS need one. Results are much better when transplant is done before leukemia develops, which is one reason regular marrow monitoring matters. Transplant teams usually use gentler, reduced-intensity preparation, because people with SDS are more sensitive to its heart and lung side effects. Other care depends on the person: orthopedic follow-up and occasionally surgery for hip or knee problems, regular dental care because low neutrophils raise the risk of gum disease and cavities, and early developmental, speech or educational support when needed.
SDS is lifelong, but its effects change with age, and severity varies widely, even among people with the same genetic changes. Digestive problems are often worst in infancy. Pancreatic function frequently improves as children grow, and about half of older children develop normal stool patterns, though many continue to need enzymes and most remain smaller than their peers. Delays in sitting, walking or talking are common early on, and most children reach their expected milestones by school age, although some have learning difficulties that benefit from support. With ongoing treatment and monitoring, many children with SDS attend school and take part in ordinary activities. The bone marrow needs lifelong attention. Estimates vary, but by early adulthood roughly a quarter to a third of people with SDS develop MDS or AML, and the risk continues to rise with age. Typical surveillance includes a complete blood count every 3 to 6 months and a bone marrow examination every 1 to 3 years, or more often if counts change. Newer genetic tests on blood or marrow can find groups of cells with acquired changes; some of these are considered lower risk, while others, particularly changes in a gene called TP53, signal a higher risk of leukemia and may lead to closer monitoring or earlier transplant planning. Other routine follow-up usually includes growth, nutrition and vitamin checks about every 6 months, bone density testing, developmental and learning assessments, and dental visits at least yearly. For many families the burden is the steady rhythm of appointments and the background worry about leukemia. Adolescents gradually take on understanding their own condition, including how to recognize infection, and a careful handoff of records and plans helps when moving from pediatric to adult care. Genetic counseling is also useful for adults with SDS who are planning a family.
Ask about an evaluation for SDS when an infant or child has persistent greasy or foul-smelling stools with poor weight gain, especially together with low neutrophil counts or repeated infections. Adults with unexplained ongoing neutropenia and short stature may also warrant assessment. For someone with SDS, call the care team right away for a fever or other signs of infection, because low neutrophils increase the risk of serious infection and antibiotics are usually started quickly; the hematology team can give a written plan for exactly what to do. Contact the team promptly as well about new or unusual bruising, a pinpoint red or purple rash, bleeding gums or nosebleeds, or new paleness and tiredness, since these can signal falling blood counts or a change in the marrow.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Shwachman-Diamond Syndrome is like, what's helped you, or ask the community a question.